There would be a few holders disappointed in a sub 40c buyout price and I would be one of them. Wouldn't argue with a return to the 55c buyout price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025